Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Carcinoma, Hepatocellular 15Small Cell Lung Carcinoma 11Triple Negative Breast Neoplasms 9Neoplasms 8Colorectal Neoplasms 6Breast Neoplasms 6Urinary Bladder Neoplasms 5Lung Neoplasms 5Carcinoma, Renal Cell 5Ovarian Neoplasms 4Carcinoma, Transitional Cell 3Carcinoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Melanoma 2Colonic Neoplasms 2Venous Thrombosis 1Urologic Neoplasms 1Stomach Neoplasms 1Squamous Non-Small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Skin Diseases 1Rectal Neoplasms 1Radiation Pneumonitis 1Prostatic Neoplasms, Castration-Resistant 1Peritoneal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1Non-Squamous Non-Small Cell Lung Cancer 1Non-Small-Cell Lung 1

Interventions

tislelizumab 1sugemalimab 1sintilimab 1pembrolizumab 1durvalumab 1camrelizumab 1atezolizumab 1Radiotherapy 1Nivolumab 1Immunotherapy 1Cisplatin 1Breath Holding 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiation Pneumonitis × atezolizumab × Clear all
NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡